Related references
Note: Only part of the references are listed.Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes
Mette Julsgaard et al.
INFLAMMATORY BOWEL DISEASES (2020)
Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease
Myung S. Ko et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Cesarean section and the risk of neonatal respiratory distress syndrome: a meta-analysis
Yan Li et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
Noninvasive Methods For Assessing Inflammatory Bowel Disease Activity in Pregnancy A Systematic Review
Parul Tandon et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2019)
Head-to-head comparison of three stool calprotectin tests for home use
Sjoukje-Marije Haisma et al.
PLOS ONE (2019)
Maternal Inflammation: potential mediators and effects on pregnancy outcomes
Maria A. Kennelly et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2019)
Reference Intervals for Fecal Calprotectin in Pregnant Women Using a Particle Enhanced Turbidimetric Assay
Tove Fall et al.
CLINICAL LABORATORY (2019)
Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease A Prospective Observational Study
Lillian Du et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2018)
Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study
M. Chaparro et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability
Andrea Padoan et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease
Heidi Kammerlander et al.
INFLAMMATORY BOWEL DISEASES (2018)
Pregnancy-Onset Inflammatory Bowel Disease: A Subtle Diagnosis
Benjamin Koslowsky et al.
INFLAMMATORY BOWEL DISEASES (2018)
Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis
Yuen Sau Tham et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2018)
Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease
Mette Julsgaard et al.
INFLAMMATORY BOWEL DISEASES (2017)
The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease
Heidi Kammerlander et al.
INFLAMMATORY BOWEL DISEASES (2017)
Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide
Anke Heida et al.
INFLAMMATORY BOWEL DISEASES (2017)
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Jean-Frederic Colombel et al.
LANCET (2017)
Pregnancy does not affect fecal calprotectin concentration in healthy women
Anita Balint et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2017)
Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease
Matthijs Oyaert et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies
Alison de Lima-Karagiannis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Su1255 Fecal Calprotectin Is Elevated With Clinical Disease Activity During Pregnancy in Women With Inflammatory Bowel Disease
Vivian Huang et al.
GASTROENTEROLOGY (2015)
Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery
Emily K. Wright et al.
GASTROENTEROLOGY (2015)
A Prospective Study of the Safety of Lower Gastrointestinal Endoscopy During Pregnancy in Patients with Inflammatory Bowel Disease
A. de Lima et al.
JOURNAL OF CROHNS & COLITIS (2015)
Intrapartum Corticosteroid use Significantly Increases the Risk of Gestational Diabetes in Women with Inflammatory Bowel Disease
Yvette P. Y. Leung et al.
JOURNAL OF CROHNS & COLITIS (2015)
Human calprotectin is an iron-sequestering host-defense protein
Toshiki G. Nakashige et al.
NATURE CHEMICAL BIOLOGY (2015)
Effects of maternal inflammation and exposure to cigarette smoke on birth weignt and delivery of preterm babies in a cohort of Indigenous Australian women
Kirsty G. Pringle et al.
FRONTIERS IN IMMUNOLOGY (2015)
Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2013)
Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits
S. J. Whitehead et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2013)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Expression pattern of tumor necrosis factor alpha in placentae of idiopathic fetal growth restriction
Shaima M. Almasry et al.
JOURNAL OF MOLECULAR HISTOLOGY (2012)
Risk Factors and Outcomes Associated With First-Trimester Fetal Growth Restriction
Dennis O. Mook-Kanamori et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
A meta-analysis on the influence of inflammatory bowel disease on pregnancy
J. Cornish et al.
GUT (2007)
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy
Alexander C. von Roon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term
Shiliang Liu et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
Geert D'Haens et al.
GASTROENTEROLOGY (2007)
Share Paper
